Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon Health Authority

Opioid Settlement Prevention, Treatment and Recovery Board

OSPTR Board Purpose

The Opioid Settlement Prevention, Treatment and Recovery Board (OSPTR Board) will determine how to allocate the State’s portion of Oregon’s opioid settlement funds. The OSPTR Board’s role and membership were established by the Oregon State Legislature in March 2022 through House Bill 4098.

OHA provides staff support and works with OSPTR Board members to convene and organize Board meetings. If you would like to submit a letter or statement to the OSPTR Board, please send it to lisa.m.shields@oha.oregon.gov.

OSPTR Board Timeline (View full-sized image)

OSPTR Board Timeline_Oct 2022.JPG  
For more information on Oregon's opioid settlement funds, visit www.oregon.gov/opioidsettlement

​​​​​​
​​1. A policy advisor to the Governor​
April Rohman​​
Behavioral Health Policy Advisor,
Governor's Behavioral Health Initiative​
​​
​​​​​​​​​​2. A representative of the Department of Justice,
David Hart
Sr. Assistant Attorney General,
Department of Justice​​​

​ ​
​​​​3. ​A representative of the Oregon Health Authority
John W. McIlveen, PhD, LMHC
State Opioid Treatment Authority,
Oregon Health Authority

​4. A representative of the Department of Human Services
Tami Kane-Suleiman, MSW
Child Fatality Prevention & Review Program Manager,
Oregon Department of Human Services

​5. The Director of the Alcohol and Drug Policy Commission​
Annaliese Dolph ​​​
Director, Alcohol and Drug Policy Commission,
Oregon Health Authority​​​
​6. The Chairperson of the Oversight and Accountability Council ​
​established in ORS 430.388 or designee
​​Zebuli Payne, CADCII​​
Clinical Director,
Phoenix Wellness Center​​


​7. An individual representing Clackamas, Washington, or Multnomah County
Nicholas Ocón, LCSW
Behavioral Health Division Manager,
Washington County Dept. of Health and Human Services

​​​8. An individual representing Clatsop, Columbia, Coos, Curry, Jackson, Josephine, Lane, or Yamhill County
Laurie Trieger,
Lane County Commissioner

​9. An individual representing the City of Portland
Skyler Brocker-Knapp, BA, MA, JD
Senior Policy Advisor to Portland Mayor​

​10. An individual representing a city with a population above 10,000 residents as of July 21, 2021
Dr. Joann Linville
Wilsonville City Councilor​


11. An individual representing a city with a population at or below 10,000 residents as of July 21, 2021
Julia Hajduk,
Community Development Director,
City of Stayton


​12. A representative of the Oregon Coalition of Local Health Officials
Carrie Brogoitti,
Director of Public Health,
Union County Center for Human Development​

​13. A representative of a community mental health program
Rick Treleaven, LCSW,
Chief Executive Officer,
BestCare Treatment Services, Inc.

​14. An individual who has experienced a substance use disorder or a representative of an organization that advocates on behalf of individuals with substance use disorders
Fernando Peña,
Executive Director,
NW Instituto Latino

​​​15. An individual representing law enforcement, first responders, or jail commanders or wardens
Captain Lee Eby,
Jail Commander,
Clackamas County Sheriff's Office

​16. A member of the House of Representatives appointed by the Speaker of the House of Representatives (nonvoting)
Hai Pham, DMD
Oregon St​​​​ate Representative

​17. A member of the Senate appointed by the President of the Senate (nonvoting)
Lew Frederick,
Oregon State Senator


​​​​18. The State Court Administrator (nonvoting)​
Ann Lininger,
Clackamas County Circuit Court Judge

​OSPTR Board members will serve four-year terms and are eligible for reappointment. Ex-officio members will serve on the OSPTR Board based on the mandated member representation (for example, the Director of the Alcohol and Drug Policy Commission). Before a member’s term expires, the department shall appoint a successor whose term will begin January 1 of the following term. If there is a vacancy for any cause, the department shall make an appointment to become effective immediately.

Read the OSPTR Board By-Laws


Statutory Rules of Operation

Statute lists the following rules of operation for the OSPTR Board:

  • The Governor shall select one co-chairperson from the members in positions #1-12 to represent state entities
  • Members in positions #13-18 shall select a co-chairperson from one of their members to represent cities or counties
  • The Oregon Health Authority shall provide staff support to the board
  • Decision-making by the board shall be based on consensus and supported by at least a majority of the members
  • The board shall document all objections to board decisions
  • The board shall conduct at least four public meetings in accordance with Oregon's public meeting law. They willl be publicized to facilitate attendance, and the board will receive testimony and input from the community during the meetings
  • The board shall establish a process for the public to provide written comments and proposals at each meeting of the board
  • The board shall be guided and informed by:
    1. The comprehensive 2020 - 2025 Addiction, Prevention, Treatment and Recovery Plan developed by the Alcohol and Drug Policy Commission
    2. The board’s ongoing evaluation of the efficacy of the funding allocations
    3. Evidence-based and evidence-informed strategies and best practices
    4. Input the board receives from the public
    5. Equity considerations for underserved populations
    6. The terms of the settlement agreements


Satutory Rules of Fund Allocation

Statute lists the following rules for determining how the State’s portion of Oregon’s opioid settlement funds may be allocated:

  • No more than five percent of the moneys may be spent on administering the board and the fund
  • A portion of the moneys shall be allocated toward a unified and evidence-based state system for collecting, analyzing and publishing data about the availability and efficacy of substance use prevention, treatment and recovery services statewide
  • Opioid settlement funds shall be allocated for funding evidence-based or evidence-informed statewide and regional programs identified in the Distributor Settlement Agreement, the Janssen Settlement Agreement and any other judgment or judgment or settlement described in section 5 (1)(c) of 2022 HB4098, including but not limited to programs that:
    1. Treat opioid use disorders and any co-occurring substance use disorders or mental health conditions
    2. Support individuals in recovery from opioid use disorders and any co-occurring substance use disorders or mental health conditions
    3. Provide connections to care for individuals who have or are at risk of developing opioid use disorders and any co-occurring substance use disorders or mental health conditions
    4. Address the needs of individuals with opioid use disorders and any co-occurring substance use disorders or mental health conditions and who are involved in, at risk of becoming involved in, or in transition from, the criminal justice system
    5. Address the needs of pregnant or parenting women with opioid use disorders and any co-occurring substance use disorders or mental health conditions, and the needs of their families, including babies with neonatal abstinence syndrome
    6. Support efforts to prevent over-prescribing of opioids and ensure appropriate prescribing and dispensing of opioids
    7. Support efforts to discourage or prevent misuse of opioids
    8. Support efforts to prevent or reduce overdose deaths or other opioid-related harms
    9. Educate law enforcement or other first responders regarding appropriate practices and precautions when dealing with users of fentanyl or other opioids
    10. Provide wellness and support services for first responders and others who experience secondary trauma associated with opioid-related emergency events
    11. Support efforts to provide leadership, planning, coordination, facilitation, training and technical assistance to abate the opioid epidemic through activities, programs or strategies
    12. Provide funding to support opioid abatement research


Upcoming Meetings

Recent Meetings

Archived Meetings

All Archived Meetings